Biotechnology - Oxford BioTherapeutics


Current filters:

Oxford BioTherapeutics

Popular Filters

Oxford BioTherapeutics and Menarini progress enhanced antibody for acute myeloid leukemia


UK-based Oxford BioTherapeutics and Berlin-Chemie, a subsidiary of family-owned Italian drugmaker Menarini,…

BiotechnologyEuropeMenariniOncologyOxford BioTherapeuticsResearch

Menarini in $1 billion partnership with Oxford BioTherapeutics for cancer drug development


In a second major deal within just over a year for the UK-based antibody-based drug developer, BioTherapeutics…

BiotechnologyLicensingMenariniOncologyOxford BioTherapeuticsPharmaceuticalResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top